To put it into perspective, for someone weighing 240 lbs, this translates to an average loss of 33 lbs with Semaglutide, compared to 48 lbs with tirzepatide
Its inclusion in the Golo Release formula suggests a potential benefit for mood stabilization and metabolic health
Additionally, the expression of genes involved in GLP-1 biosynthesis was increased (proglucagon and prohormone convertase 3) 5
[10] [11] Eligibility is assessed on an individual basis by a clinician in line with NICE guidance
[138] Further investigation into CV and renal benefits is underway, particularly concerning heart failure and chronic kidney disease, with ongoing research assessing whether these benefits extend to nondiabetic populations
Bartolms T, Mayer B, Balola AH, Salama A